Denali Therapeutics Inc (DNLI)

P/OCF Ratio

-8.06×

TTM · Retrieved:

DNLI logo

DNLI P/OCF Ratio

Current (TTM)-8.06×
DNLI Quarterly P/OCF Ratio (-7.13× → -49.67×)
High-resolution chart · PNG

DNLI p/ocf ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Denali Therapeutics Inc P/OCF Ratio — Quarterly
Period endingP/OCF Ratio
-49.6663×
-27.3119×
-29.3981×
-23.3332×
-31.8545×
-17.7124×
-41.4066×
-83.4691×
-40.7364×
-27.0353×
-30.0713×
-32.5035×
-35.7365×
-53.4935×
-50.8556×
-66.4271×
-84.0321×
-54.7285×
-83.1914×
-148.233×
-175.4689×
-137.2495×
19.5844×
44,783.6262×
-58.9584×
-32.9107×
-34.9392×
-48.2524×
-46.0281×
-75.5541×
20.907×
-57.9658×
-33.8733×
52.5195×
-26.2236×
-80.6529×
-83.3192×
-10.2836×
-10.5316×
-6.8461×
-7.1297×
-7.1297×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.